Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Analyst Support
$5,300
BUY NOW GET FREE SAMPLE

FAQs

Global Inferior Vena Cava Filters Market size was valued at USD 783.6 million in 2022 and is poised to grow from USD 849.66 million in 2023 to USD 1623.45 million by 2031, growing at a CAGR of 8.43% in the forecast period (2024-2031).

The competitive landscape of the inferior vena cava filters market is characterized by the presence of key industry players and emerging entrants focusing on innovation, product development, and strategic collaborations. Leading companies such as Boston Scientific Corporation, Cook Medical, Cordis Corporation (a Cardinal Health company), B. Braun Melsungen AG, and C.R. Bard, Inc. (acquired by BD) dominate the market with their established product portfolios and global presence. These players continually invest in research and development to enhance their offerings and address the evolving needs of healthcare professionals and patients. 'Boston Scientific Corporation', 'Cook Medical', 'Cordis Corporation (a Cardinal Health company)', 'B. Braun Melsungen AG', 'C.R. Bard, Inc. (acquired by BD)', 'Johnson & Johnson', 'Medtronic plc', 'Abbott Laboratories', 'Terumo Corporation', 'Becton, Dickinson and Company (BD)', 'Merit Medical Systems, Inc.', 'Argon Medical Devices, Inc.', 'Teleflex Incorporated', 'Cardinal Health, Inc.', 'ALN Implants Chirurgicaux'

The rising prevalence of VTE cases, including deep vein thrombosis (DVT) and pulmonary embolism (PE), drives the demand for inferior vena cava filters as preventive measures.

Retrievable Filters Dominance: The market is witnessing a shift towards retrievable filters due to their flexibility and potential for removal, aligning with patient-centric care and minimizing long-term risks.

The largest region in the inferior vena cava filters market is North America. The region's dominance can be attributed to its well-established healthcare infrastructure, high awareness about venous thromboembolism (VTE) risks, and a significant prevalence of conditions warranting the use of inferior vena cava filters. The United States, in particular, contributes significantly to the market due to its advanced medical facilities and widespread adoption of medical technologies.

Feedback From Our Clients

Global Inferior Vena Cava Filters Market

Product ID: SQMIG35A2557

$5,300
BUY NOW GET FREE SAMPLE